2019-10-24
With the trend of medical digitalization, “Wearable Painless Real-Time Glucose Monitoring System and Cloud Data Platform” is an integration of brand new technology for measuring blood glucose, which includes the technology of Electrochemical enzyme biosensor, Biosensor chips data transportation, AIoT data analysis, Platform data storage server、Big data analytics、chemical enzyme development and so on.
The monitoring system is using the unique chemical formulation self-developed by Seknova Biotechnology Co., Ltd., together with the biochip technology and development of cloud software from Microtek, integrating the medical material verification and regulation counselling of the Instrument Technology Research Center (ITRC), combining the clinical functionality experiment conducted by Asia University Hospital, and lastly, Microtek performs big data analytics with cloud.
The “Wearable Painless Real-Time Glucose Monitoring System and Cloud Data Platform” is able to conduct continuous blood glucose monitoring, CGM. With the risk assessment of medical system and monitoring disease occurrence, expert decision system can be executed, and diabetic patients are able to manage their own health and lifestyle. In addition, with the cloud technology of large broadband data traffic and the diversification of applied vehicles, services are diversified, and treatment and prevention management can also be reached.
Moreover, the cloud technology can also be used in the field of home care to satisfy the instant need of information interaction between doctors and patients, in order to enhance the accuracy of disease management. Further, it can be extended to the category of caring and supporting services, and improve the life quality of the patients.
Welcome to R508 for our services and further collaborations.
》Cooperation projects and needs:Local and international collaboration for clinical application;Academia and industry collaboration for research and development.